Imunon, Inc.
- IMNN
- NASDAQ
- Biotechnology
- DNA-based Immunotherapies
- Cancer Vaccines
- Directed Chemotherapies
$0.98
Today −3.43%Quote Oct 19, 2026, 08:00 PM UTC
−27.57%over the last month
Max drawdown −34.8%From 1-month high −34.8%3 months −41.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Imunon
Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
20
Market value
$5.5M
Quote Oct 19
Analyst target
$10.00
+915.2% from here
Floor
$0.96
2.5% below price
Resistance
$0.99
0.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IMNNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free